The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Tumor suppressor protein (p)53, is a regulator of NF-κB repression by the glucocorticoid receptor
Open accessAbstract
Glucocorticoids can inhibit inflammation by abrogating the activity of NF-κB, a family of transcription factors that regulates the production of proinflammatory cytokines. To understand the molecular mechanism of repression of NF-κB activity by glucocorticoids, we performed a high-throughput siRNA oligo screen to identify novel genes involved in this process. Here, we report that loss of p53, a tumor suppressor protein, impaired repression of NF-κB target gene transcription by glucocorticoids. Additionally, loss of p53 also impaired transcription of glucocorticoid receptor (GR) target genes, whereas upstream NF-κB and glucocorticoid receptor signaling cascades remained intact. We further demonstrate that p53 loss severely impaired glucocorticoid rescue of death in a mouse model of LPS shock. Our findings unveil a new role for p53 in the repression of NF-κB by glucocorticoids and suggest important implications for treatment of the proinflammatory microenvironments found in tumors with aberrant p53 activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“p53 can suppress NF-κB (Dey et al., 2007; Murphy et al., 2011), which promotes transcription of many SASP genes (Freund et al., 2011).”
From Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype (2016) · cites this paper as Murphy et al., 2011
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607
NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182
Function and Activation of NF-kappaB in the Immune System
Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001041 · Cited by 4,745
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
NF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
Self-citationLive or let die: the cell's response to p53
Vousden, K. H., & Lu, X. (2002) · Nature Reviews Cancer · doi:10.1038/nrc864 · Cited by 3,192
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., & Karin, M. (1995) · Science · doi:10.1126/science.270.5234.286 · Cited by 2,390
IKK-1 and IKK-2: Cytokine-Activated IκB Kinases Essential for NF-κB Activation
Mercurio, F., Zhu, H., Murray, B. W., Shevchenko, A., Bennett, B. L., Li, J. W., Young, D. B., Barbosa, M., Mann, M., Manning, A., et al. (1997) · Science · doi:10.1126/science.278.5339.860 · Cited by 2,040
Steroid Receptor Interactions with Heat Shock Protein and Immunophilin Chaperones*
Pratt, W. B., & Toft, D. O. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.3.0303 · Cited by 1,791
Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation.
Verma, I. M., Stevenson, J. K., Schwarz, E. M., Van Antwerp, D., & Miyamoto, S. (1995) · Genes & Development · doi:10.1101/gad.9.22.2723 · Cited by 1,724
Self-citationRole of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids
Scheinman, R. I., Cogswell, P. C., Lofquist, A. K., & Baldwin, A. S. (1995) · Science · doi:10.1126/science.270.5234.283 · Cited by 1,699
Phosphorylation of NF-κB and IκB proteins: implications in cancer and inflammation
Viatour, P., Merville, M.-P., Bours, V., & Chariot, A. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.11.009 · Cited by 1,496
NF-κB: A lesson in family values
Thanos, D., & Maniatis, T. (1995) · Cell · doi:10.1016/0092-8674(95)90506-5 · Cited by 1,247
Zhong, H., Voll, R. E., & Ghosh, S. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80066-0 · Cited by 1,210
Ray, A., & Prefontaine, K. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.752 · Cited by 1,064
Nuclear receptor coactivators and corepressors
Horwitz, K. B. (1996) · Molecular Endocrinology · doi:10.1210/me.10.10.1167 · Cited by 942
CREB-binding protein/p300 are transcriptional coactivators of p65
Gerritsen, M. E., Williams, A. J., Neish, A. S., Moore, S., Shi, Y., & Collins, T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.2927 · Cited by 816
McKay, L. I., & Cidlowski, J. A. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.4.0375 · Cited by 805
Glucocorticoid Therapy for Immune-Mediated Diseases: Basic and Clinical Correlates
Boumpas, D. T., Chrousos, G. P., Wilder, R. L., Cupps, T. R., & Balow, J. E. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-12-199312150-00007 · Cited by 778
Vermeulen, L. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg139 · Cited by 760
At the Crossroads of Inflammation and Cancer
Clevers, H. (2004) · Cell · doi:10.1016/j.cell.2004.09.005 · Cited by 493
Signal-induced ubiquitination of Ikappa Balpha by the F-box protein Slimb/beta -TrCP
Spencer, E., Jiang, J., & Chen, Z. J. (1999) · Genes & Development · doi:10.1101/gad.13.3.284 · Cited by 431
A New First Step in Activation of Steroid Receptors
Davies, T. H., Ning, Y.-M., & Sánchez, E. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c100531200 · Cited by 427 · cited 1×
“Upon passive diffusion and subsequent binding by glucocorticoids, GR can dissociate from its inhibitory complex and translocate to the nucleus via active transport by dynein (13).”
BackgroundA Transcriptional Switch Mediated by Cofactor Methylation
Xu, W., Chen, H., Du, K., Asahara, H., Tini, M., Emerson, B. M., Montminy, M., & Evans, R. M. (2001) · Science · doi:10.1126/science.1065961 · Cited by 416
Self-citationMolecular mechanisms of glucocorticoid action and resistance
Schaaf, M. J. M., & Cidlowski, J. A. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(02)00263-7 · Cited by 416
A probability-based approach for the analysis of large-scale RNAi screens
König, R., Chiang, C.-Y., Tu, B. P., Yan, S. F., DeJesus, P. D., Romero, A., Bergauer, T., Orth, A., Krueger, U., Zhou, Y., et al. (2007) · Nature Methods · doi:10.1038/nmeth1089 · Cited by 338
Self-citationGLUCOCORTICOID AND MINERALOCORTICOID RECEPTORS: Biology and Clinical Relevance
Funder, M. (1997) · Annual Review of Medicine · doi:10.1146/annurev.med.48.1.231 · Cited by 320
Essential role of RelA Ser311 phosphorylation by PKC in NF- B transcriptional activation
Duran, A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg370 · Cited by 319
Mechanisms of glucocorticoid signalling
Schoneveld, O. J. L. M., Gaemers, I. C., & Lamers, W. H. (2004) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/j.bbaexp.2004.09.004 · Cited by 310
Folding of the Glucocorticoid Receptor by the Heat Shock Protein (hsp) 90-based Chaperone Machinery
Dittmar, K. D., Demady, D. R., Stancato, L. F., Krishna, P., & Pratt, W. B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.21213 · Cited by 268
Glucocorticoid signalling—multiple variations of a common theme
Reichardt, H. M., & Schütz, G. (1998) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(98)00208-1 · Cited by 170
McKay, L. I., & Cidlowski, J. A. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.8.0506 · Cited by 165
Marco, B. D., Massetti, M., Bruscoli, S., Macchiarulo, A., Virgilio, R. D., Velardi, E., Donato, V., Migliorati, G., & Riccardi, C. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl1080 · Cited by 145
Sengupta, S., & Wasylyk, B. (2001) · Genes & Development · doi:10.1101/gad.202201 · Cited by 138
Negative cross‐talk between p53 and the glucocorticoid receptor and its role in neuroblastoma cells
Sengupta, S., Vonesch, J., Waltzinger, C., Zheng, H., & Wasylyk, B. (2000) · The EMBO Journal · doi:10.1093/emboj/19.22.6051 · Cited by 110
Maiyar, A. C., Phu, P. T., Huang, A. J. Y., & Firestone, G. L. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.3.9893 · Cited by 104
Crochemore, C., Michaelidis, T. M., Fischer, D., Loeffler, J., & Almeida, O. F. X. (2002) · The FASEB Journal · doi:10.1096/fj.01-0577com · Cited by 96
Yang, N., Zhang, W., & Shi, X. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21562 · Cited by 81
Cohen, B., John, P., Yakushin, S. B., Buettner-Ennever, J. A., & Raphan, T. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb07553.x · Cited by 63
Maas, K. H., Westfall, M. D., Pietenpol, J. A., Olsen, N. J., & Aune, T. M. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20931 · Cited by 56
Yamanishi, Y., Boyle, D. L., Green, D. R., Keystone, E. C., Connor, A. M., Zollman, S., & Firestein, G. S. (2004) · Arthritis Research & Therapy · doi:10.1186/ar1448 · Cited by 56
Fifty Years of Experience with Cortisone Therapy in the Study and Treatment of Rheumatoid Arthritis
Neeck, G. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04199.x · Cited by 53
Urban, G., Golden, T. A., Aragon, I. V., Cowsert, L. M., Cooper, S. R., Dean, N. M., & Honkanen, R. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210993200 · Cited by 51
Regulation of human glucocorticoid receptor gene transcription by Sp1 and p53
Suehiro, T., Kaneda, T., Ikeda, Y., Arii, K., Kumon, Y., & Hashimoto, K. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2004.05.005 · Cited by 17
P53 and p73 differ in their ability to inhibit glucocorticoid receptor (GR) transcriptional activity
Zhang, L., Nie, L., & Maki, C. G. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-68 · Cited by 8
Cited by
Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype
Wiley, C. D., Velarde, M. C., Lecot, P., Liu, S., Sarnoski, E. A., Freund, A., Shirakawa, K., Lim, H. W., Davis, S. S., Ramanathan, A., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.11.011 · Cited by 1,275
“p53 can suppress NF-kB (Dey et al., 2007; Murphy et al., 2011), which promotes transcription of many SASP genes (Freund et al.”
BackgroundOne Hormone, Two Actions: Anti- and Pro-Inflammatory Effects of Glucocorticoids
Cruz-Topete, D., & Cidlowski, J. A. (2015) · Neuroimmunomodulation · doi:10.1159/000362724 · Cited by 454
Busillo, J. M., & Cidlowski, J. A. (2013) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.11.005 · Cited by 339
Liu, F., Xia, Y., Parker, A. S., & Verma, I. M. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01107.x · Cited by 241
Self-citationPetta, I., Dejager, L., Ballegeer, M., Lievens, S., Tavernier, J., De Bosscher, K., & Libert, C. (2016) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00064-15 · Cited by 203
Metadata
- Authors
- Murphy, S. H., Suzuki, K., Downes, M., Welch, G. L., De Jesus, P., Miraglia, L. J., Orth, A. P., Chanda, S. K., Evans, R. M., & Verma, I. M.
- Affiliations
- Salk Institute for Biological Studies (US)
- Genomics Institute of the Novartis Research Foundation (US)
- Genomics Institute of the Novartis Research Foundation, San Diego, CA 92121
- Corresponding author
- Verma, Inder M.
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2011-09-26
- Volume
- 108
- Issue
- 41
- Pages
- 17117-17122
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3193198
- OpenAlex
- W1976330765
- Cited by
- 93
- References
- 46
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 6 · 2023: 2 · 2022: 6 · 2021: 4 · 2020: 8 · 2019: 2 · 2018: 6 · 2017: 6 · 2016: 9 · 2015: 7 · 2014: 9 · 2013: 14 · 2012: 5
- FWCI
- 3.15
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- March of Dimes Foundation
- Sanofi
- Leona M. and Harry B. Helmsley Charitable Trust
- California Institute of Regenerative Medicine
- Ipsen
- National Institutes of Health (DK057978)
- National Heart, Lung, and Blood Institute (R01HL105278, HL2782081)
- National Cancer Institute (CA014495, P30CA014195)
- National Institute of General Medical Sciences (P50GM085764)
- National Institute of Allergy and Infectious Diseases (R01AI048034, R37AI048034, AI048034)
- National Institute of Diabetes and Digestive and Kidney Diseases (R37DK057978, DK057978)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD027183)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- p53, NF-κB, glucocorticoid receptor, inflammation, inflammatory cytokines, siRNA screen, tumor microenvironment, transcriptional repression, tumor suppressor
- MeSH terms
- Animals, Dexamethasone, Lipopolysaccharides, Mice, Inbred C57BL, Receptors, Glucocorticoid, RNA, Messenger, Shock, Septic, Signal Transduction, Tumor Suppressor Protein p53, NF-kappa B, Mice, Knockout, RNA Interference, RNA, Small Interfering, Mice, High-Throughput Screening Assays, Protein Interaction Maps
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.